126 related articles for article (PubMed ID: 1435205)
1. Evaluation of experimental early acute cerebral ischemia before the development of edema: use of dynamic, contrast-enhanced and diffusion-weighted MR scanning.
Finelli DA; Hopkins AL; Selman WR; Crumrine RC; Bhatti SU; Lust WD
Magn Reson Med; 1992 Sep; 27(1):189-97. PubMed ID: 1435205
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
3. Iron-dextran as a magnetic susceptibility contrast agent: flow-related contrast effects in the T2-weighted spin-echo MRI of normal rat and cat brain.
White DL; Aicher KP; Tzika AA; Kucharczyk J; Engelstad BL; Moseley ME
Magn Reson Med; 1992 Mar; 24(1):14-28. PubMed ID: 1313524
[TBL] [Abstract][Full Text] [Related]
4. Acute stroke in cats: comparison of dynamic susceptibility-contrast MR imaging with T2- and diffusion-weighted MR imaging.
Maeda M; Itoh S; Ide H; Matsuda T; Kobayashi H; Kubota T; Ishii Y
Radiology; 1993 Oct; 189(1):227-32. PubMed ID: 8372198
[TBL] [Abstract][Full Text] [Related]
5. Early MR detection of experimentally induced cerebral ischemia using magnetic susceptibility contrast agents: comparison between gadopentetate dimeglumine and iron oxide particles.
Reith W; Forsting M; Vogler H; Heiland S; Sartor K
AJNR Am J Neuroradiol; 1995 Jan; 16(1):53-60. PubMed ID: 7900602
[TBL] [Abstract][Full Text] [Related]
6. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
[TBL] [Abstract][Full Text] [Related]
7. Hepatic in vivo video microscopic study for evaluating experimental and approved magnetic resonance contrast agents.
Kruskal JB; Lunderquist A; Clouse ME
Invest Radiol; 1994 Jun; 29 Suppl 2():S83-6. PubMed ID: 7928279
[No Abstract] [Full Text] [Related]
8. Role of spatial distribution in proton relaxation enhancement by particulate iron oxide.
Tanimoto A; Yuasa Y; Stark DD
Invest Radiol; 1994 Jun; 29 Suppl 2():S78-80. PubMed ID: 7523329
[No Abstract] [Full Text] [Related]
9. Basic physics of MR contrast agents and maximization of image contrast.
Hendrick RE; Haacke EM
J Magn Reson Imaging; 1993; 3(1):137-48. PubMed ID: 8428081
[TBL] [Abstract][Full Text] [Related]
10. Application of a superparamagnetic iron oxide (Resovist) for MR imaging of human cerebral blood volume.
Reimer P; Schuierer G; Balzer T; Peters PE
Magn Reson Med; 1995 Nov; 34(5):694-7. PubMed ID: 8544689
[TBL] [Abstract][Full Text] [Related]
11. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
Low RN; Francis IR
AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver.
Pauleit D; Textor J; Bachmann R; Conrad R; Flacke S; Layer G; Kreft B; Schild H
Radiology; 2002 Jan; 222(1):73-80. PubMed ID: 11756708
[TBL] [Abstract][Full Text] [Related]
13. MR contrast agents in acute experimental cerebral ischemia: potential adverse impacts on neurologic outcome and infarction size.
Doerfler A; Engelhorn T; Heiland S; Knauth M; Wanke I; Forsting M
J Magn Reson Imaging; 2000 Apr; 11(4):418-24. PubMed ID: 10767071
[TBL] [Abstract][Full Text] [Related]
14. MRI susceptometry: image-based measurement of absolute susceptibility of MR contrast agents and human blood.
Weisskoff RM; Kiihne S
Magn Reson Med; 1992 Apr; 24(2):375-83. PubMed ID: 1569876
[TBL] [Abstract][Full Text] [Related]
15. The evolution of acute stroke recorded by multimodal magnetic resonance imaging.
Quast MJ; Huang NC; Hillman GR; Kent TA
Magn Reson Imaging; 1993; 11(4):465-71. PubMed ID: 7802856
[TBL] [Abstract][Full Text] [Related]
16. MRI in acute cerebral ischaemia: perfusion imaging with superparamagnetic iron oxide in a rat model.
Forsting M; Reith W; Dörfler A; von Kummer R; Hacke W; Sartor K
Neuroradiology; 1994; 36(1):23-6. PubMed ID: 8107990
[TBL] [Abstract][Full Text] [Related]
17. Basic principles of MR contrast.
Nelson KL; Runge VM
Top Magn Reson Imaging; 1995; 7(3):124-36. PubMed ID: 7654392
[TBL] [Abstract][Full Text] [Related]
18. Acute cerebral ischemia: evaluation with dynamic contrast-enhanced MR imaging and MR angiography.
Warach S; Li W; Ronthal M; Edelman RR
Radiology; 1992 Jan; 182(1):41-7. PubMed ID: 1727307
[TBL] [Abstract][Full Text] [Related]
19. Comparison of USPIO-enhanced MRI and Gd-DTPA enhancement during the subacute stage of focal cerebral ischemia in rats.
Yang YM; Feng X; Yin le K; Li CC; Jia J; Du ZG
Acta Radiol; 2014 Sep; 55(7):864-73. PubMed ID: 24065200
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
Kim YK; Kwak HS; Han YM; Kim CS
J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
